KELLY QUINN: Open Payments
NPI 1821457037 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 22 payments from 9 companies in 2025. Trend: 2023 $174 · 2024 $587 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $243 |
| Novo Nordisk Inc | 5 | $149 |
| Ethicon US, LLC | 1 | $113 |
| INTUITIVE SURGICAL, INC. | 1 | $108 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Intra-Sana Laboratories | 1 | $24 |
| Integra LifeSciences Corporation | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: ZEPBOUND, Wegovy, Echelon Flex, Da Vinci Surgical System, KEYTRUDA, RELTONE 200 MG, ACCLARENT AERA, JARDIANCE.
Industry payments across LA — which companies pay providers there.
